Trials / Terminated
TerminatedNCT02688465
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Parkinson's disease is not only a pathology of movements. There are many non-motor symptoms that complicate and impair patients' quality of life. Among those disorders are sleep disorders. Insomnia is the most frequent symptom. Most patients report 2-5 awakenings per night and long periods of awakening which occupy 30 to 40% of their night. Apomorphine is a dopamine agonist that may be administered with a pump . The objective of the study is to assess changes in the quality of sleep in Parkinson's disease patients treated with an apomorphine pump.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apomorphine |
Timeline
- Start date
- 2016-09-05
- Primary completion
- 2017-01-01
- Completion
- 2017-07-01
- First posted
- 2016-02-23
- Last updated
- 2018-03-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02688465. Inclusion in this directory is not an endorsement.